25-year life sciences and technology veteran named President of Ciox RWD business
Ciox, a leading health technology company, today announces Tal Rosenberg as President, Real World Data (RWD). A 25-year veteran in creating new value ecosystems and markets at the intersection of Life Sciences and Information Technology, Rosenberg has held various senior leadership roles within technology organizations. Rosenberg’s rich experience positions him well to lead Ciox RWD in its mission to become the leading provider of deep clinical data and services to Life Sciences and RWD marketplaces.
Securing Rosenberg’s leadership is the latest of several important advancements for Ciox’s growing Real World Data business, including a groundbreaking collaboration with LabCorp, an expanding partnership with Merck, and the acquisition of biomedical natural language processing firm, Medal.
“The addition of Tal Rosenberg as the leader of our RWD team will accelerate our mission of liberating the power of clinical data in support of scientists and researchers working to improve health,” says Pete McCabe, CEO of Ciox. “Tal leads by example, sets a compelling vision and invests in people and their ideas. He brings a proven track record of success in growing industry-leading teams and products. We will lean on this track record as we expand industry use of real-world data and advance patient care by getting the data that tells a full patient story into the hands of researchers.”
Rosenberg succeeds Stephen Kahane, MD, a critical member of Ciox’s executive advisory team who served as interim CEO and President of Real World Data. Kahane will serve as executive advisor to Rosenberg to ensure a seamless transition.
“Joining the Ciox Real World Data team at such a pivotal moment in the organization’s future is an honor,” says Rosenberg. “Ciox’s incredible team has built a reputation for success in the clinical data marketplace, advancing groundbreaking collaborations and furthering partnerships, expanding data rights, and building a strong market offering with an industry-leading outlook.”
Prior to joining Ciox, Rosenberg led the Global Technology Solutions organization at IQVIA, managing the innovation, design, development, delivery, supply chain and operating model of the company’s Global Technology Solutions offerings.
A leader in the Life Sciences technology marketplace, Rosenberg regularly speaks at customer and industry venues worldwide on topics related to digital disruption and technology innovation. He holds a BA in Economics and Information Systems and an MBA from New York University’s Stern School of Business.
Ciox Health, a leading health technology company, simply and securely connects healthcare decision makers with the data and hidden insights in patient medical records. Combined with the industry’s most extensive network access to healthcare data, Ciox Health’s expertise, relationships, technology and scale make a difference for healthcare stakeholders and empower greater health for patients. Through its technology platform, which includes solutions for data acquisition, release of information, clinical coding, data abstraction, and analytics, Ciox helps clients securely and consistently solve the last mile challenges in clinical interoperability. For more information, visit www.cioxhealth.com.